Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Non-cash Items (2016 - 2025)

Palisade Bio has reported Non-cash Items over the past 11 years, most recently at $69683.0 for Q4 2025.

  • Quarterly Non-cash Items rose 205.29% to $69683.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $69683.0 through Dec 2025, up 205.29% year-over-year, with the annual reading at $69683.0 for FY2025, 205.29% up from the prior year.
  • Non-cash Items was $69683.0 for Q4 2025 at Palisade Bio, down from $200000.0 in the prior quarter.
  • Over five years, Non-cash Items peaked at $1.1 million in Q2 2022 and troughed at $22825.0 in Q4 2024.
  • The 5-year median for Non-cash Items is $250000.0 (2024), against an average of $355683.5.
  • Year-over-year, Non-cash Items plummeted 97.13% in 2023 and then soared 1115.51% in 2024.
  • A 5-year view of Non-cash Items shows it stood at $759743.0 in 2021, then skyrocketed by 44.79% to $1.1 million in 2022, then tumbled by 94.17% to $64155.0 in 2023, then tumbled by 64.42% to $22825.0 in 2024, then soared by 205.29% to $69683.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Non-cash Items are $69683.0 (Q4 2025), $200000.0 (Q3 2025), and $200000.0 (Q2 2025).